+958.0%
MRNA vs ENB
+136.8%
+821.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.8% | -4.1% | -4.8% |
| 7D | -20.9% | -1.0% | -19.9% | -20.8% |
| 30D | -13.3% | +0.7% | -14.0% | -13.3% |
| 3M | +212.6% | -7.7% | +220.2% | +213.5% |
| 6M | +309.0% | -14.7% | +323.7% | +314.5% |
| YTD | +567.3% | +3.2% | +564.1% | +552.6% |
| 1Y | +689.7% | +2.3% | +687.4% | +673.3% |
| 3Y | +157.4% | +64.4% | +93.1% | +131.2% |
| 5Y | -21.7% | +57.7% | -79.5% | -28.5% |
| All | +958.0% | +136.8% | +821.2% | +811.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling